|
Novo Nordisk |
Details
|
Novo Nordisk Pharmaceuticals is a healthcare company that is a world leader in diabetes care. The company discovers, manufactures, and markets its pharmaceutical services and products. The Novo Nordisk company operates in 2 groups: Biopharmaceutical and Diabetes care. The biopharmaceutical group offers growth hormone therapy, hormone replacement therapy, hemostasis management and other products. The company’s Diabetes Care group offers human insulin, insulin analogues, oral antidiabetic medications and insulin-related sales. In our country Novo Nordisk task is to change the course of diabetes for good. The company sells its products in Europe, Japan, and in North America. Working as a catalyst to improve diabetes treatment and prevention, the industry strives to be the preferred partner for patients, employees, healthcare providers and others in the health care system, who shares its vision to defeat diabetes. NovoNordisk was established in 1931 and is based in Bagsvaerd, Denmark. Novo Nordisk is a publicly traded company on the New York Stock Exchange, trading under the symbol: NVO.
|
| Category |
Pharmaceutical Companies > N
|
| Related Searches |
novo nordisk us, novonordisk |
| Date Submitted |
20-Aug-2005
|
|
